Covered recipient · General Payments record
WHITNEY L PFLANZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$386.31
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.61 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $79.44 | 4 |
| Lilly USA, LLC | $67.14 | 4 |
| Novo Nordisk AS | $61.31 | 4 |
| Nevro Corp. | $26.05 | 1 |
| Amgen Inc. | $18.04 | 1 |
| Mylan Specialty L.P. | $15.68 | 1 |
| Kowa Pharmaceuticals America, Inc. | $15.56 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.06 | 1 |
| Exact Sciences Corporation | $13.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.22 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843519 | CMS |
| ABBVIE INC. | $26.34 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843521 | CMS |
| ABBVIE INC. | $17.75 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843523 | CMS |
| ABBVIE INC. | $16.13 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843525 | CMS |
| Amgen Inc. | $18.04 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117352785 | CMS |
| Exact Sciences Corporation | $13.33 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114498359 | CMS |
| Kowa Pharmaceuticals America, Inc. | $15.56 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113474291 | CMS |
| Lilly USA, LLC | $16.24 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135990030 | CMS |
| Lilly USA, LLC | $20.15 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135993466 | CMS |
| Lilly USA, LLC | $13.72 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135985754 | CMS |
| Lilly USA, LLC | $17.03 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135977664 | CMS |
| Mylan Specialty L.P. | $15.68 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147375591 | CMS |
| Nevro Corp. | $26.05 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130766927 | CMS |
| Novo Nordisk Inc | $13.50 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100324122 | CMS |
| Novo Nordisk Inc | $16.88 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100258028 | CMS |
| Novo Nordisk Inc | $14.48 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100462912 | CMS |
| Novo Nordisk Inc | $16.45 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100634177 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.06 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151196745 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.